Blog

The market expects ANI Pharmaceuticals (ANIP) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Construction Partners (ROAD) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

The market expects Essent Group (ESNT) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

The market expects Costamare (CMRE) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

Opus Genetics, Inc. (IRD) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when Enbridge (ENB) reports results for the quarter ended March 2025. While this widely-known consensus outlook

The market expects Veren (VRN) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

The market expects Algonquin Power & Utilities (AQN) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known

Wall Street expects a year-over-year decline in earnings on lower revenues when Alpha Metallurgical (AMR) reports results for the quarter ended March 2025. While this widely-known consensus outlook

Brookfield Renewable Energy Partners (BEP) reported $857 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 2.1%. EPS of -$0.35 for the same period

CBOE Global (CBOE) reported $565.2 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 12.6%. EPS of $2.50 for the same period compares to $2.15 a year

Imperial Oil (IMO) reported $8.72 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 4.3%. EPS of $1.75 for the same period compares to $1.65 a year ago.

Shares of Eastern Bankshares, Inc. (EBC) have gained 0.2% over the past four weeks to close the last trading session at $14.95, but there could still be a solid upside left in the stock if

Shares of DigitalBridge (DBRG) have gained 7.9% over the past four weeks to close the last trading session at $8.74, but there could still be a solid upside left in the stock if short-term price

Shares of Byline Bancorp (BY) have gained 3% over the past four weeks to close the last trading session at $25.76, but there could still be a solid upside left in the stock if short-term price

Rambus (RMBS) closed the last trading session at $48.88, gaining 5.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Trupanion (TRUP) closed the last trading session at $36.44, gaining 4.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Under Armour (UAA) closed the last trading session at $5.80, gaining 8.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Synovus Financial (SNV) closed the last trading session at $44.10, gaining 10% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Shares of Celestica (CLS) have gained 28.9% over the past four weeks to close the last trading session at $89.21, but there could still be a solid upside left in the stock if short-term price

Shares of Axos Financial (AX) have gained 9.5% over the past four weeks to close the last trading session at $65.50, but there could still be a solid upside left in the stock if short-term price

Innospec (IOSP) closed the last trading session at $90.02, gaining 1.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Shares of Lam Research (LRCX) have gained 10% over the past four weeks to close the last trading session at $71.73, but there could still be a solid upside left in the stock if short-term price

Shares of Pacific Premier Bancorp (PPBI) have gained 5.3% over the past four weeks to close the last trading session at $20.79, but there could still be a solid upside left in the stock if

Shares of iTeos Therapeutics, Inc. (ITOS) have gained 31.6% over the past four weeks to close the last trading session at $7.50, but there could still be a solid upside left in the stock if